Esmo Congress 2019: Focus on Breast Cancer

Oncology (Williston Park). 2019 Nov 14;33(11):687515.
No abstract available

Publication types

  • Congress

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • BRCA1 Protein / genetics
  • BRCA2 Protein / genetics
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics
  • Female
  • Humans
  • Precision Medicine / methods
  • Randomized Controlled Trials as Topic
  • Receptor, ErbB-2 / genetics

Substances

  • Antineoplastic Agents
  • BRCA1 Protein
  • BRCA1 protein, human
  • BRCA2 Protein
  • BRCA2 protein, human
  • ERBB2 protein, human
  • Receptor, ErbB-2